{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:53:52Z","timestamp":1790916832141,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":180,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004343","name":"Stavros Niarchos Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004343","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101310","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T14:43:23Z","timestamp":1784904203000},"page":"101310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comprehensive molecular profiling of advanced NSCLC in Greek patients:A prospective HeCOG study"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1478-0087","authenticated-orcid":false,"given":"Paris A.","family":"Kosmidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4646-448X","authenticated-orcid":false,"given":"Thanos","family":"Kosmidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0389-4209","authenticated-orcid":false,"given":"Kyriaki","family":"Papadopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Korfiatis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8342-3839","authenticated-orcid":false,"given":"Athanasios","family":"Vozikis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Lampaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8871-3264","authenticated-orcid":false,"given":"Panagiota","family":"Economopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Fountzila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athina","family":"Christopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Epaminondas","family":"Samantas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios","family":"Vagionas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7780-7836","authenticated-orcid":false,"given":"Giannis Socrates","family":"Mountzios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Gkoumas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1455-1503","authenticated-orcid":false,"given":"Nikolaos","family":"Tsoukalas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilias","family":"Athanasiadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Bafaloukos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Panopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8152-3185","authenticated-orcid":false,"given":"Margarita Ioanna","family":"Koufaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Petrakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Fountzilas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2906-6607","authenticated-orcid":false,"given":"Helena","family":"Linardou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2026.101310_bib0001","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","article-title":"Lung cancer","volume":"398","author":"Thai","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ctarc.2026.101310_bib0002","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S1470-2045(23)00444-8","article-title":"Global variations in lung cancer incidence by histological subtype in 2020: a population-based study","volume":"24","author":"Zhang","year":"2023","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ctarc.2026.101310_bib0003","first-page":"1","article-title":"Immunotherapy for advanced non-small cell lung cancer: a decade of progress","volume":"41","author":"Shields","year":"2021","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"10.1016\/j.ctarc.2026.101310_bib0004","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920937902","article-title":"Resistance to immune checkpoint inhibitors in non-small cell lung cancer: biomarkers and therapeutic strategies","volume":"12","author":"Walsh","year":"2020","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101310_bib0005","doi-asserted-by":"crossref","DOI":"10.1200\/CCI-25-00234","article-title":"SNF-CLIMEDIN:a randomized trial of digital support and intervention in patients with advanced non-small cell lung cancer. A HECOG study","volume":"10","author":"Kosmidis","year":"2026","journal-title":"JCO Clin. Cancer Inform."},{"key":"10.1016\/j.ctarc.2026.101310_bib0006","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40364-024-00566-0","article-title":"Oncogenic alterations in advanced NSCLC: a molecular super-highway","volume":"12","author":"Friedlaender","year":"2024","journal-title":"Biomark. Res."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101310_bib0007","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5306\/wjco.v12.i4.217","article-title":"Oncogenic driver mutations in non-small cell lung cancer: past, present and future","volume":"12","author":"Chevallier","year":"2021","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2026.101310_bib0008","doi-asserted-by":"crossref","first-page":"531","DOI":"10.21873\/cgp.20155","article-title":"Genotyping KRAS and EGFR mutations in Greek patients with non-small cell lung cancer: incidence, significance and implications for treatment","volume":"16","author":"Linardou","year":"2019","journal-title":"Cancer Genom. Proteom."},{"issue":"14","key":"10.1016\/j.ctarc.2026.101310_bib0019","doi-asserted-by":"crossref","first-page":"188","DOI":"10.21037\/atm-22-412","article-title":"Genomic landscape and prognosis of patients with TP53-mutated non-small cell lung cancer","volume":"10","author":"Fan","year":"2022","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ctarc.2026.101310_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107293","article-title":"KRAS G12C in advanced NSCLC: prevalence, co-mutations, and testing","volume":"184","author":"Lim","year":"2023","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ctarc.2026.101310_bib0010","article-title":"KRAS mutation in advanced non-small cell lung cancer: from biology to novel therapeutic strategies","author":"Liguori","year":"2024","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101310_bib0011","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1158\/2159-8290.CD-14-1236","article-title":"Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles and therapeutic vulnerabilities","volume":"5","author":"Skoulidis","year":"2015","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ctarc.2026.101310_bib0015","first-page":"1","article-title":"Impact of KRAS and TP53 co-mutations on outcomes after first-line systemic therapy among patients with STK11-mutated advanced non\u2013small-cell lung cancer","volume":"3","author":"Bange","year":"2019","journal-title":"JCO Prec. Oncol."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101310_fur1","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMoa0904554","article-title":"Screening for epidermal growth factor receptor mutations in lung cancer","volume":"361","author":"Rosell","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ctarc.2026.101310_fur2","doi-asserted-by":"crossref","first-page":"583929","DOI":"10.1155\/2011\/583929","article-title":"TP53 mutations in non-small cell lung cancer","volume":"1","author":"Mogi","year":"2011","journal-title":"Biomed. Res. Int."},{"issue":"7511","key":"10.1016\/j.ctarc.2026.101310_fur3","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature13385","article-title":"Cancer genome atlas research network: comprehensive molecular profiling of lung adenocarcinoma","volume":"511","year":"2014","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101310_fur4","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41588-023-01355-5","article-title":"Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer","volume":"55","author":"Ravi","year":"2023","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101310_fur5","doi-asserted-by":"crossref","first-page":"699","DOI":"10.21037\/tlcr-23-853","article-title":"ATM-the gene at the moment in non-small cell lung cancer","volume":"13","author":"Thu","year":"2024","journal-title":"Transl. Lung Cancer Res."},{"issue":"23","key":"10.1016\/j.ctarc.2026.101310_fur6","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.1158\/1078-0432.CCR-23-1122","article-title":"ATM mutations associate with distinct co-mutational patterns and therapeutic vulnerabilities in NSCLC","volume":"29","author":"Vokes","year":"2023","journal-title":"Clin. Cancer Res."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226002212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226002212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:58:27Z","timestamp":1790913507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226002212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":19,"alternative-id":["S2468294226002212"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101310","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive molecular profiling of advanced NSCLC in Greek patients:A prospective HeCOG study","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101310","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101310"}}